Olafur S. Palsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Olafur S. Palsson has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- William E. Whitehead
Department of Medicine University of North Carolina Chapel Hill North Carolina USA
7 shared publications - Ami D. Sperber
Faculty of Health Sciences Ben‐Gurion University of the Negev Beer‐Sheva Israel
3 shared publications Andrew D. Feld
3 shared publicationsMichael Von Korff
3 shared publicationsRona L. Levy
3 shared publications- Shrikant I. Bangdiwala
Population Health Research Institute, McMaster University, Hamilton, ON, Canada
3 shared publications
Latest Publications
- Open Access
- 27 March 2026
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 35 (1) , 59-66
Prevalence and Impact of Disorders of Gut-Brain Interaction in Indonesia: An Analysis from the Rome Foundation Global Epidemiology Study
Background and Aims: Disorders of gut-brain interaction (DGBI) significantly impact quality of life (QoL), healthcare utilization, and work productivity globally, yet data from Indonesia remain limited. This household face-to-face survey study aimed to investigate the prevalence and impact of DGBI on psychological distress, dietary habits, QoL, and healthcare utilization among the Indonesian population based on Rome IV criteria. Methods: A total of 1,339 Indonesian participants from the Rome Foundation Global Epidemiology Study were included in the final analysis. The overall prevalence of DGBI diagnoses in Indonesia was examined, including age- and sex-specific prevalence rates. Additionally, the association of DGBI with psychological distress (somatization, anxiety, depression), QoL, healthcare utilization, and dietary patterns were assessed. Results: In Indonesia, the overall prevalence of DGBI was 18.2% (95%CI: 16.2-20.4%). Based on anatomical sites, bowel disorders were most prevalent (13.2%; 95%CI: 11.5-15.1%), followed by gastroduodenal disorders (6.0%; 95%CI: 4.9-7.4%), anorectal disorders (2.0%; 95%CI: 1.4-2.9%), and esophageal disorders (1.9%; 95%CI: 1.2-2.7%). Participants with DGBI (n=244) exhibited significantly higher psychological distress, including increased somatization, anxiety, and depression, as well as lower QoL compared to those without DGBI (n=1,095). Additionally, individuals with DGBI demonstrated significantly higher healthcare utilization rates. Dietary patterns also differed markedly in DGBI participants, characterized by significantly higher consumption of milk and pasta and reduced intake of vegetables, legumes, and rice. Conclusions: DGBI represents a significant health burden in Indonesia, substantially impacting psychological well-being, dietary behaviors, healthcare resource utilization, and overall QoL, consistent with global trends.
- 27 March 2026
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 35 (1) , 59-66
Open AccessPrevalence and Impact of Disorders of Gut-Brain Interaction in Indonesia: An Analysis from the Rome Foundation Global Epidemiology Study
Background and Aims: Disorders of gut-brain interaction (DGBI) significantly impact quality of life (QoL), healthcare utilization, and work productivity globally, yet data from Indonesia remain limited. This household face-to-face survey study aimed to investigate the prevalence and impact of DGBI on psychological distress, dietary habits, QoL, and healthcare utilization among the Indonesian population based on Rome IV criteria. Methods: A total of 1,339 Indonesian participants from the Rome Foundation Global Epidemiology Study were included in the final analysis. The overall prevalence of DGBI diagnoses in Indonesia was examined, including age- and sex-specific prevalence rates. Additionally, the association of DGBI with psychological distress (somatization, anxiety, depression), QoL, healthcare utilization, and dietary patterns were assessed. Results: In Indonesia, the overall prevalence of DGBI was 18.2% (95%CI: 16.2-20.4%). Based on anatomical sites, bowel disorders were most prevalent (13.2%; 95%CI: 11.5-15.1%), followed by gastroduodenal disorders (6.0%; 95%CI: 4.9-7.4%), anorectal disorders (2.0%; 95%CI: 1.4-2.9%), and esophageal disorders (1.9%; 95%CI: 1.2-2.7%). Participants with DGBI (n=244) exhibited significantly higher psychological distress, including increased somatization, anxiety, and depression, as well as lower QoL compared to those without DGBI (n=1,095). Additionally, individuals with DGBI demonstrated significantly higher healthcare utilization rates. Dietary patterns also differed markedly in DGBI participants, characterized by significantly higher consumption of milk and pasta and reduced intake of vegetables, legumes, and rice. Conclusions: DGBI represents a significant health burden in Indonesia, substantially impacting psychological well-being, dietary behaviors, healthcare resource utilization, and overall QoL, consistent with global trends.
- Open Access
- 27 March 2025
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 34 (1) , 40-46
Effect of Vegan Diet During Greek-Orthodox Religious Fasting on Symptoms of Disorders of Gut-Brain Interaction
Background and Aims: Religious fasting observed in diverse populations may influence the reporting of digestive symptoms. Greek-Orthodox (Byzantine style) religious fasting is prolonged and similar to a vegan diet. We aimed to evaluate the association between functional gastrointestinal symptoms and disorders of gut-brain interaction (DGBI) with this religious fasting. Methods: We investigated Romanian participants in the Rome Foundation Global Epidemiology Study who observe Greek-Orthodox religious fasting, by adding specific questions on religious fasting to the study questionnaire. Data were analyzed in connection with the reported gastrointestinal symptoms. Results: 2015 Romanians were included in the analyses. Overall, 716 (35.5%) of the respondents practiced some fasting, of which 446 (62.3%) fasted on Easter and Christmas, 90 (12.6%) observed all fasts, and 625 (87.3%) practiced weekly fasting. Of the latter, 167 (23.3%) fasted every week and 90 (12.6%) reported symptoms during fasting. There were no statistically significant associations between Greek-Orthodox fasting, to any degree, with upper or lower DGBI or gastrointestinal symptoms. Conclusions: The results from this representative sample show that a substantial proportion of the Romanian population adheres to Greek-Orthodox fasting. However, in contrast to the a priori hypothesis, we did not have sufficient evidence that religious fasting is associated with the prevalence of DGBI, or with functional gastrointestinal symptoms.
- 27 March 2025
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 34 (1) , 40-46
Open AccessEffect of Vegan Diet During Greek-Orthodox Religious Fasting on Symptoms of Disorders of Gut-Brain Interaction
Background and Aims: Religious fasting observed in diverse populations may influence the reporting of digestive symptoms. Greek-Orthodox (Byzantine style) religious fasting is prolonged and similar to a vegan diet. We aimed to evaluate the association between functional gastrointestinal symptoms and disorders of gut-brain interaction (DGBI) with this religious fasting. Methods: We investigated Romanian participants in the Rome Foundation Global Epidemiology Study who observe Greek-Orthodox religious fasting, by adding specific questions on religious fasting to the study questionnaire. Data were analyzed in connection with the reported gastrointestinal symptoms. Results: 2015 Romanians were included in the analyses. Overall, 716 (35.5%) of the respondents practiced some fasting, of which 446 (62.3%) fasted on Easter and Christmas, 90 (12.6%) observed all fasts, and 625 (87.3%) practiced weekly fasting. Of the latter, 167 (23.3%) fasted every week and 90 (12.6%) reported symptoms during fasting. There were no statistically significant associations between Greek-Orthodox fasting, to any degree, with upper or lower DGBI or gastrointestinal symptoms. Conclusions: The results from this representative sample show that a substantial proportion of the Romanian population adheres to Greek-Orthodox fasting. However, in contrast to the a priori hypothesis, we did not have sufficient evidence that religious fasting is associated with the prevalence of DGBI, or with functional gastrointestinal symptoms.
- Open Access
- 21 January 2025
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 16 (4) , e00811
Digital Therapeutic Combining Hypnosis and Diaphragmatic Breathing Intervention for Functional Abdominal Bloating: A Feasibility Study
INTRODUCTION: Abdominal bloating is a difficult symptom to treat. Hypnotherapy and diaphragmatic intervention have separately shown benefit on bloating in prior work but have not been united into a single intervention. We aimed to obtain data on the potential therapeutic impact of a novel audio-recorded bloating treatment for bloating integrating hypnosis and diaphragmatic breathing, with proposed synergistic effect. METHODS: Patients with nonorganic bowel disorders with predominant bloating symptoms completed a digitally delivered 7-session audio-recorded hypnotherapy program without clinician involvement. The intervention combined bloating-targeted hypnotic suggestions and guided diaphragmatic breathing delivered under hypnosis, and was supplemented with interval self-guided breathing exercises. Participants completed online REDCap assessments at baseline, midtreatment, at end of treatment, and 3-month follow-up, evaluating symptom severity, gastrointestinal symptom-specific anxiety, overall anxiety/depression, and quality of life. Outcomes were assessed in an intention-to-treat manner with repeated measures analysis of variances (ANOVAs) with Bonferroni-adjusted pairwise post hoc tests. RESULTS: Of 23 patients who started treatment, 22 (95.6%) completed follow-up. Bloating severity on Irritable Bowel Syndrome-Symptom Severity Scale and Patient Assessment of Upper Gastrointestinal Symptom Severity Index showed reduction in bloating with large effect sizes (Cohen d of ∼0.8) at the end of treatment, as did Visceral Sensitivity Index bloating-related anxiety. At the end of treatment, 16 patients (69.6%) were Irritable Bowel Syndrome-Symptom Severity Scale treatment responders (≥30% symptom reduction) on bloating and 17 (73.9%) on overall bowel symptom severity. Anxiety, depression, and quality-of-life scores were unchanged. Outcome measures were fully maintained at the 3-month follow-up. DISCUSSION: Results suggest the therapeutic utility of a new cost-effective self-administered bloating intervention. A randomized controlled trial is planned to confirm these therapeutic effects.
- 21 January 2025
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 16 (4) , e00811
Open AccessDigital Therapeutic Combining Hypnosis and Diaphragmatic Breathing Intervention for Functional Abdominal Bloating: A Feasibility Study
INTRODUCTION: Abdominal bloating is a difficult symptom to treat. Hypnotherapy and diaphragmatic intervention have separately shown benefit on bloating in prior work but have not been united into a single intervention. We aimed to obtain data on the potential therapeutic impact of a novel audio-recorded bloating treatment for bloating integrating hypnosis and diaphragmatic breathing, with proposed synergistic effect. METHODS: Patients with nonorganic bowel disorders with predominant bloating symptoms completed a digitally delivered 7-session audio-recorded hypnotherapy program without clinician involvement. The intervention combined bloating-targeted hypnotic suggestions and guided diaphragmatic breathing delivered under hypnosis, and was supplemented with interval self-guided breathing exercises. Participants completed online REDCap assessments at baseline, midtreatment, at end of treatment, and 3-month follow-up, evaluating symptom severity, gastrointestinal symptom-specific anxiety, overall anxiety/depression, and quality of life. Outcomes were assessed in an intention-to-treat manner with repeated measures analysis of variances (ANOVAs) with Bonferroni-adjusted pairwise post hoc tests. RESULTS: Of 23 patients who started treatment, 22 (95.6%) completed follow-up. Bloating severity on Irritable Bowel Syndrome-Symptom Severity Scale and Patient Assessment of Upper Gastrointestinal Symptom Severity Index showed reduction in bloating with large effect sizes (Cohen d of ∼0.8) at the end of treatment, as did Visceral Sensitivity Index bloating-related anxiety. At the end of treatment, 16 patients (69.6%) were Irritable Bowel Syndrome-Symptom Severity Scale treatment responders (≥30% symptom reduction) on bloating and 17 (73.9%) on overall bowel symptom severity. Anxiety, depression, and quality-of-life scores were unchanged. Outcome measures were fully maintained at the 3-month follow-up. DISCUSSION: Results suggest the therapeutic utility of a new cost-effective self-administered bloating intervention. A randomized controlled trial is planned to confirm these therapeutic effects.
- 16 September 2024
- Published by Springer Nature in Mindfulness
- Vol. 15 (9) , 2233-2244
Mindfulness Training Has Long-Term Therapeutic Benefits in Women With Irritable Bowel Syndrome
Objectives Mindfulness training (MT) has been shown to have substantial therapeutic effects on irritable bowel syndrome (IBS) symptom severity, health-related quality of life, and psychological symptoms at 3 months following an 8-week group MT intervention. This study reports a secondary analysis to examine the long-term trajectory of change in these IBS symptoms. Methods This study analyzed 6- and 12-month follow-up data collected in a randomized controlled pilot study involving 75 adult women meeting Rome II criteria for IBS assigned to 8 weekly 2-hr sessions plus one half-day intensive of either a group mindfulness training (MT) or a validated IBS support group (SG). Outcome measures included the IBS Symptom Severity Scale (IBS-SSS), the IBS-Quality of Life (IBS-QOL) and Visceral Sensitivity Index (VSI) questionnaires, and the Brief Symptom Inventory-18 psychological distress measure. Measures were mailed to all participants who attended at least one treatment session. Analysis included mixed effects models comparing the trajectory of change over time between groups. Results At 6-month follow-up, MT patients had significantly lower mean IBS-SSS scores compared to SG patients (− 123.79 vs. − 51.82, respectively, p = 0.004). At 12-month follow-up, effects were attenuated, with IBS-SSS scores of − 88.93 (p = 0.001) for MT and − 33.63 (p = 0.158) for SG participants, with a clinically important between-group difference of 61 points (p = 0.107). VSI scores significantly improved at both 6- and 12-month follow-up compared to baseline, for the MT group only. Anxiety and depression significantly improved at 6 months, in the MT group only. Conclusions Beneficial effects of an 8-week MT program tailored for IBS persist for up to 12 months after the training. Preregistration ClinicalTrials.gov identifier: NCT00680693.
- 16 September 2024
- Published by Springer Nature in Mindfulness
- Vol. 15 (9) , 2233-2244
Mindfulness Training Has Long-Term Therapeutic Benefits in Women With Irritable Bowel Syndrome
Objectives Mindfulness training (MT) has been shown to have substantial therapeutic effects on irritable bowel syndrome (IBS) symptom severity, health-related quality of life, and psychological symptoms at 3 months following an 8-week group MT intervention. This study reports a secondary analysis to examine the long-term trajectory of change in these IBS symptoms. Methods This study analyzed 6- and 12-month follow-up data collected in a randomized controlled pilot study involving 75 adult women meeting Rome II criteria for IBS assigned to 8 weekly 2-hr sessions plus one half-day intensive of either a group mindfulness training (MT) or a validated IBS support group (SG). Outcome measures included the IBS Symptom Severity Scale (IBS-SSS), the IBS-Quality of Life (IBS-QOL) and Visceral Sensitivity Index (VSI) questionnaires, and the Brief Symptom Inventory-18 psychological distress measure. Measures were mailed to all participants who attended at least one treatment session. Analysis included mixed effects models comparing the trajectory of change over time between groups. Results At 6-month follow-up, MT patients had significantly lower mean IBS-SSS scores compared to SG patients (− 123.79 vs. − 51.82, respectively, p = 0.004). At 12-month follow-up, effects were attenuated, with IBS-SSS scores of − 88.93 (p = 0.001) for MT and − 33.63 (p = 0.158) for SG participants, with a clinically important between-group difference of 61 points (p = 0.107). VSI scores significantly improved at both 6- and 12-month follow-up compared to baseline, for the MT group only. Anxiety and depression significantly improved at 6 months, in the MT group only. Conclusions Beneficial effects of an 8-week MT program tailored for IBS persist for up to 12 months after the training. Preregistration ClinicalTrials.gov identifier: NCT00680693.
- Open Access
- 15 September 2022
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 31 (3) , 273-282
Epidemiology and Burden of Disorders of Gut-Brain Interaction in Romania: A Subgroup Analysis of the Rome Foundation Global Epidemiology Study
Background and Aims: Disorders of gut-brain interaction (DGBI) are a group of chronic illnesses that are crucial to public health because they are widespread, influence patients‘ quality of life and functional level, and exert a major socioeconomic impact. We assessed the national prevalence of all 22 DGBI, the percentage of respondents satisfying diagnostic criteria for at least one DGBI, and the impact on the disease burden in Romania using data from the Rome Foundation Global Epidemiology Study. Methods: Data were collected through an anonymous, nationwide, and secure online survey, which evaluated the prevalence of any DGBI as well as over 22 different DGBI. The Rome IV diagnostic questionnaire and an in-depth supplemental questionnaire were included in the survey, which was completed through the Internet with numerous built-in quality-assurance measures. Results: The survey was completed by 2,049 participants (mean age 42.29±13.11 years) with a representative national distribution. Diagnostic criteria for any DGBI were met in 40.1% of the subjects, while 28.6% met criteria for only one DGBI (no overlap), and 11.5% met criteria for DGBIs in two, three, or four overlapping gastrointestinal anatomical regions. Females had a substantially higher predominance of DGBI than males. Psychosocial characteristics (such as quality of life, somatization, and concern about digestive problems) and healthcare utilization (such as physician visits and medication use) were associated with having any DGBI. Conclusions: We provide the first comprehensive evaluation of the prevalence and burden of DGBI in Romania using the Rome IV criteria. The burden of DGBI in Romania is substantial, with 40.1% of the 2,049 participants meeting diagnostic criteria for any DGBI. These findings demonstrate the importance of patient care, and the need for training and future research.
- 15 September 2022
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 31 (3) , 273-282
Open AccessEpidemiology and Burden of Disorders of Gut-Brain Interaction in Romania: A Subgroup Analysis of the Rome Foundation Global Epidemiology Study
Background and Aims: Disorders of gut-brain interaction (DGBI) are a group of chronic illnesses that are crucial to public health because they are widespread, influence patients‘ quality of life and functional level, and exert a major socioeconomic impact. We assessed the national prevalence of all 22 DGBI, the percentage of respondents satisfying diagnostic criteria for at least one DGBI, and the impact on the disease burden in Romania using data from the Rome Foundation Global Epidemiology Study. Methods: Data were collected through an anonymous, nationwide, and secure online survey, which evaluated the prevalence of any DGBI as well as over 22 different DGBI. The Rome IV diagnostic questionnaire and an in-depth supplemental questionnaire were included in the survey, which was completed through the Internet with numerous built-in quality-assurance measures. Results: The survey was completed by 2,049 participants (mean age 42.29±13.11 years) with a representative national distribution. Diagnostic criteria for any DGBI were met in 40.1% of the subjects, while 28.6% met criteria for only one DGBI (no overlap), and 11.5% met criteria for DGBIs in two, three, or four overlapping gastrointestinal anatomical regions. Females had a substantially higher predominance of DGBI than males. Psychosocial characteristics (such as quality of life, somatization, and concern about digestive problems) and healthcare utilization (such as physician visits and medication use) were associated with having any DGBI. Conclusions: We provide the first comprehensive evaluation of the prevalence and burden of DGBI in Romania using the Rome IV criteria. The burden of DGBI in Romania is substantial, with 40.1% of the 2,049 participants meeting diagnostic criteria for any DGBI. These findings demonstrate the importance of patient care, and the need for training and future research.
- 3 August 2021
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 67 (7) , 3017-3025
Pilot Study of a Self-Administered Hypnosis Intervention for Functional Dyspepsia
Background Functional dyspepsia (FD) is a chronic disorder of the upper gastrointestinal tract that currently lacks substantially effective therapy options. Aims To evaluate the feasibility and potential impact on FD symptoms and well-being of a fully automated gut-directed hypnosis intervention delivered via audio recordings. Methods FD patients were enrolled at a single medical center and given access to a password-protected website where they completed 7 bi-weekly audio-recorded hypnosis sessions over a 3-month period. Study questionnaires including the Patient assessment of upper gastrointestinal symptom severity index, Short-Form Nepean Dyspepsia Index, the Visceral Sensitivity Index, and the Brief Symptom Inventory (BSI-18) were completed online pre-treatment, mid-treatment, post-treatment and at 3-month follow-up. Results Of 23 enrolled patients (18 females; mean age = 38 years), 96% completed the entire treatment program and 3-month follow-up. Intention-to-treat analyses showed significant improvement at both end of treatment and 3-month follow-up in dyspepsia severity and quality of life, as well as in gut-specific anxiety and psychological distress. 68% of treatment completers reported that their FD symptoms were improved. Improvement in FD severity was significantly positively correlated with baseline PAGI-SYM total scores and BSI Global Severity Index scores. Conclusions The fully automated hypnosis audio treatment program, which requires no therapist or clinician involvement, demonstrated excellent feasibility and resulted in significant improvement in FD symptoms, quality of life and emotional well-being. The results indicate that the intervention has high potential as adjunctive therapy for FD and warrants further investigation in a randomized controlled trial.
- 3 August 2021
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 67 (7) , 3017-3025
Pilot Study of a Self-Administered Hypnosis Intervention for Functional Dyspepsia
Background Functional dyspepsia (FD) is a chronic disorder of the upper gastrointestinal tract that currently lacks substantially effective therapy options. Aims To evaluate the feasibility and potential impact on FD symptoms and well-being of a fully automated gut-directed hypnosis intervention delivered via audio recordings. Methods FD patients were enrolled at a single medical center and given access to a password-protected website where they completed 7 bi-weekly audio-recorded hypnosis sessions over a 3-month period. Study questionnaires including the Patient assessment of upper gastrointestinal symptom severity index, Short-Form Nepean Dyspepsia Index, the Visceral Sensitivity Index, and the Brief Symptom Inventory (BSI-18) were completed online pre-treatment, mid-treatment, post-treatment and at 3-month follow-up. Results Of 23 enrolled patients (18 females; mean age = 38 years), 96% completed the entire treatment program and 3-month follow-up. Intention-to-treat analyses showed significant improvement at both end of treatment and 3-month follow-up in dyspepsia severity and quality of life, as well as in gut-specific anxiety and psychological distress. 68% of treatment completers reported that their FD symptoms were improved. Improvement in FD severity was significantly positively correlated with baseline PAGI-SYM total scores and BSI Global Severity Index scores. Conclusions The fully automated hypnosis audio treatment program, which requires no therapist or clinician involvement, demonstrated excellent feasibility and resulted in significant improvement in FD symptoms, quality of life and emotional well-being. The results indicate that the intervention has high potential as adjunctive therapy for FD and warrants further investigation in a randomized controlled trial.
- 17 September 2019
- Published by Taylor & Francis in International Journal of Clinical and Experimental Hypnosis
- Vol. 67 (4) , 428-448
A National Survey of Clinical Hypnosis Views and Experiences of the Adult Population in the United States
A nationwide, demographically balanced Internet survey of 1000 adults (500 females, 500 males, mean age 49.5, range 18–88 years) was conducted to assess views and experiences of clinical hypnosis in the United States population. Participants were unaware when enrolling in the survey that hypnosis was the subject matter. Key findings included that most reported a positive (38.6%) or neutral (48.4%) view of clinical hypnosis, with only 12.8% expressing a negative view; 7.6% of respondents had undergone hypnosis treatment, and 63.1% reported some resulting benefit; 54.9% of individuals who had never undergone hypnosis treatment indicated that they would consider seeking such treatment; 45.6% of all respondents thought there was moderate or strong scientific evidence supporting hypnosis as a real phenomenon; 77.8% identified one or more areas where they thought clinical hypnosis had substantial practical utility, and 44.8% estimated themselves to be at least moderately hypnotizable.
- 17 September 2019
- Published by Taylor & Francis in International Journal of Clinical and Experimental Hypnosis
- Vol. 67 (4) , 428-448
A National Survey of Clinical Hypnosis Views and Experiences of the Adult Population in the United States
A nationwide, demographically balanced Internet survey of 1000 adults (500 females, 500 males, mean age 49.5, range 18–88 years) was conducted to assess views and experiences of clinical hypnosis in the United States population. Participants were unaware when enrolling in the survey that hypnosis was the subject matter. Key findings included that most reported a positive (38.6%) or neutral (48.4%) view of clinical hypnosis, with only 12.8% expressing a negative view; 7.6% of respondents had undergone hypnosis treatment, and 63.1% reported some resulting benefit; 54.9% of individuals who had never undergone hypnosis treatment indicated that they would consider seeking such treatment; 45.6% of all respondents thought there was moderate or strong scientific evidence supporting hypnosis as a real phenomenon; 77.8% identified one or more areas where they thought clinical hypnosis had substantial practical utility, and 44.8% estimated themselves to be at least moderately hypnotizable.
- Open Access
- 28 July 2009
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 9 (1) , 24
Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial
Irritable bowel syndrome (IBS), a functional bowel disorder with symptoms of abdominal pain and disturbed defecation experienced by 10% of U.S. adults, results in significant disability, impaired quality of life, and health-care burden. Conventional medical care focusing on pharmacological approaches, diet, and lifestyle management has been partially effective in controlling symptoms. Behavioral treatments, such as cognitive-behavioral therapy and hypnosis, are promising. This paper describes an on-going feasibility study to assess the efficacy of mindfulness training, a behavioral treatment involving directing and sustaining attention to present-moment experience, for the treatment of IBS.
- 28 July 2009
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 9 (1) , 24
Open AccessMindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial
Irritable bowel syndrome (IBS), a functional bowel disorder with symptoms of abdominal pain and disturbed defecation experienced by 10% of U.S. adults, results in significant disability, impaired quality of life, and health-care burden. Conventional medical care focusing on pharmacological approaches, diet, and lifestyle management has been partially effective in controlling symptoms. Behavioral treatments, such as cognitive-behavioral therapy and hypnosis, are promising. This paper describes an on-going feasibility study to assess the efficacy of mindfulness training, a behavioral treatment involving directing and sustaining attention to present-moment experience, for the treatment of IBS.
- Open Access
- 24 July 2008
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 8 (1) , 46
Complementary and alternative medicine use and cost in functional bowel disorders: A six month prospective study in a large HMO
Functional Bowel Disorders (FBD) are chronic disorders that are difficult to treat and manage. Many patients and doctors are dissatisfied with the level of improvement in symptoms that can be achieved with standard medical care which may lead them to seek alternatives for care. There are currently no data on the types of Complementary and Alternative Medicine (CAM) used for FBDs other than Irritable Bowel Syndrome (IBS), or on the economic costs of CAM treatments. The aim of this study is to determine prevalence, types and costs of CAM in IBS, functional diarrhea, functional constipation, and functional abdominal pain.
- 24 July 2008
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 8 (1) , 46
Open AccessComplementary and alternative medicine use and cost in functional bowel disorders: A six month prospective study in a large HMO
Functional Bowel Disorders (FBD) are chronic disorders that are difficult to treat and manage. Many patients and doctors are dissatisfied with the level of improvement in symptoms that can be achieved with standard medical care which may lead them to seek alternatives for care. There are currently no data on the types of Complementary and Alternative Medicine (CAM) used for FBDs other than Irritable Bowel Syndrome (IBS), or on the economic costs of CAM treatments. The aim of this study is to determine prevalence, types and costs of CAM in IBS, functional diarrhea, functional constipation, and functional abdominal pain.
- Open Access
- 3 March 2007
- Published by Springer Nature in BioPsychoSocial Medicine
- Vol. 1 (1) , 6
Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J)
Aims: To compare quality of life (QOL) for patients with irritable bowel syndrome (IBS) between the U.S. and Japan, it is indispensable to develop common instruments. The IBS-QOL, which is widely used in Western countries, was translated into Japanese as there has been a lack of Japanese disease-specific QOL measures for IBS. Methods: The original 34 items of the IBS-QOL were translated from English into Japanese through two independent forward translations, resolution, back translation, and resolution of differences. Forty nine patients who had GI symptoms but did not have any organic diseases (including 30 IBS patients diagnosed by Rome II criteria) were recruited from Tohoku University Hospital in Sendai, Japan and completed a Japanese version of the IBS-QOL (IBS-QOL-J) concomitant with a Japanese version of the IBS severity index (IBSSI-J) twice within 7–14 days. Results: The IBS-QOL-J demonstrated high internal consistency (Cronbach's alpha; 0.96) and high reproducibility (intraclass correlation coefficient; 0.92, p < 0.001). Convergent analyses confirmed that the overall score of IBS-QOL-J was significantly correlated with overall severity of IBS symptoms on the IBSSI-J (r = -0.36, p = 0.01) and with the individual items on the IBSSI-J that assess interference with life in general (r = -0.47, p = 0.001) and dissatisfaction with bowel habits (r = -0.32, p < 0.05). Eight patients who reported continuous abdominal pain in the past 6 months had significantly lower scores in the IBS-QOL-J than those who did not (53.7 +- 12.7 vs. 73.6 +- 19.5, p < 0.01). Age, sex, education or marital status did not affect scores on the measure. Conclusion: The IBS-QOL-J is a reliable instrument to assess the disease-specific QOL for IBS. Considering cross-cultural comparison, this measure is likely to be a valuable tool to investigate the QOL in Japanese patients with IBS.
- 3 March 2007
- Published by Springer Nature in BioPsychoSocial Medicine
- Vol. 1 (1) , 6
Open AccessTranslation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J)
Aims: To compare quality of life (QOL) for patients with irritable bowel syndrome (IBS) between the U.S. and Japan, it is indispensable to develop common instruments. The IBS-QOL, which is widely used in Western countries, was translated into Japanese as there has been a lack of Japanese disease-specific QOL measures for IBS. Methods: The original 34 items of the IBS-QOL were translated from English into Japanese through two independent forward translations, resolution, back translation, and resolution of differences. Forty nine patients who had GI symptoms but did not have any organic diseases (including 30 IBS patients diagnosed by Rome II criteria) were recruited from Tohoku University Hospital in Sendai, Japan and completed a Japanese version of the IBS-QOL (IBS-QOL-J) concomitant with a Japanese version of the IBS severity index (IBSSI-J) twice within 7–14 days. Results: The IBS-QOL-J demonstrated high internal consistency (Cronbach's alpha; 0.96) and high reproducibility (intraclass correlation coefficient; 0.92, p < 0.001). Convergent analyses confirmed that the overall score of IBS-QOL-J was significantly correlated with overall severity of IBS symptoms on the IBSSI-J (r = -0.36, p = 0.01) and with the individual items on the IBSSI-J that assess interference with life in general (r = -0.47, p = 0.001) and dissatisfaction with bowel habits (r = -0.32, p < 0.05). Eight patients who reported continuous abdominal pain in the past 6 months had significantly lower scores in the IBS-QOL-J than those who did not (53.7 +- 12.7 vs. 73.6 +- 19.5, p < 0.01). Age, sex, education or marital status did not affect scores on the measure. Conclusion: The IBS-QOL-J is a reliable instrument to assess the disease-specific QOL for IBS. Considering cross-cultural comparison, this measure is likely to be a valuable tool to investigate the QOL in Japanese patients with IBS.